 |
 |
 |
QMDT |
| Current: |
|
Date:
Time:
Change: |
|
|
|
|
Quick-Med Technologies, Inc. is a publicly traded Company listed under the symbol “QMDT” on the OTC Bulletin Board.
Shareholders Services
For assistance with most services related to stock ownership, contact our transfer agent, Continental Stock Transfer & Trust Company at 212.509.4000, or by e-mail at cstmail@continentalstock.com
Investor Relations
Shareholders, securities, analysts, and investors seeking additional information about the company, please contact at 561-771-1307, or by email at info@quickmedtech.com |
| |
 |
02/16/2010 - Quick-Med Technologies Expands NIMBUS® License for Derma Sciences' BIOGUARD™ Wound Dressings
Gainesville, Florida - February 16, 2010 - Quick-Med Technologies, Inc. (OTCBB: QMDT) announced today that it has amended its Patent and Technology License Agreement with Derma Sciences, Inc. (NASDAQ: DSCI) to grant Derma Sciences rights to use NIMBUS® technology in an expanded range of wound dressings formats marketed by Derma Sciences under its BIOGUARD™ trademark. The amendment also adjusts minimum royalties, provides terms for Derma Sciences entering into a private-label contract, and extends the term of the License for an additional three years subject to Derma Sciences meeting certain milestones and performance requirements. |
 Read More... |
01/29/2010 - Quick-Med’s Stay Fresh™ Technology Named as Textile World’s Quality Fabric of the Month
Gainesville, Florida – January 29, 2010 – Quick-Med Technologies, Inc. (OTCBB: QMDT) announced today that Textile World featured Quick-Med’s innovative Stay Fresh™ textiles technology as its Quality Fabric of the Month. |
| Read More... |
12/15/2009 - BIOGUARD™ Wound Dressings with NIMBUS®
Technology May Provide Safeguards
Against Influenza Viruses
Gainesville, Florida – December 15, 2009 – Quick-Med Technologies, Inc. (OTCBB:QMDT) announced today that its licensee, Derma Sciences, Inc. (OTCBB: DSCI), has reported that an independent laboratory has found that BIOGUARD™ barrier gauze dressings with Quick-Med’s novel NIMBUS antimicrobial technology exhibit high antiviral efficacy against the H1N1 virus. This new information increases the applicability of the dressings, which have already been shown to have high efficacy against virulent bacteria such as MRSA. |
| Read More... |
11/30/2009 - Quick-Med Technologies' CEO Talks With
The Wall Street Transcript
Gainesville, Florida - November 30, 2009 - Quick-Med Technologies, Inc. (OTCBB:
QMDT) announced today that The Wall Street Transcript (TWST) has included an
interview with the Company's CEO, J. Ladd Greeno, in the publication's latest
Pharmaceutical Report. |
View the Interview in PDF Format...
Read More...
|
10/23/2009 - FDA Issues Guidance for Quick-Med Technologies'
Exclusive Wound Dressing with pDADMAC
Gainesville, Florida - October 23, 2009 - Quick-Med Technologies, Inc. (OTCBB:
QMDT) announced today that the Food and Drug Administration has issued Guidance to
support the classification of the Company's NIMBUS® barrier gauze wound dressings as
Class II medical devices. This novel wound dressing received its initial market clearance
on February 25, 2009 via FDA's De Novo review process, a special clearance program
for medical devices that are found to be "not substantially equivalent" to any predicate
device. |
| Read More... |
10/14/2009 - USPTO and WIPO Publish NimbuDerm™
Patent Applications
Gainesville, Florida - October 14, 2009 - Quick-Med Technologies, Inc. (OTCBB:
QMDT), a pioneer in advanced antimicrobial technologies for medical and consumer
applications, announced today that the United States Patent and Trademark Office and
the World Intellectual Property Organization have published Company patent
applications covering Disinfectant Alcohol-Soluble Quaternary Ammonium Polymers. |
| Read More... |
06/25/2009 - Quick-Med Technologies Announces First Commercial Sales of NIMBUS® Wound Care Products
|
04/23/2009 - Quick-Med and Avery Dennison Enter Into Joint Development Agreement
|
04/09/2009 - Quick-Med Technologies to Present NIMBUS at the Symposium on Advanced Wound Care and Wound Healing Society Meeting
Gainesville, Florida – April 9, 2009 – Quick-Med Technologies, Inc., an emerging life
sciences company specializing in novel antimicrobial technologies, announced that data
on three of its proprietary antimicrobial technologies is being presented at the 2009
Symposium on Advanced Wound Care and the Wound Healing Society meeting. This
event is the premier annual meeting of physicians, researchers and other wound care
specialists and is being held in Dallas, Texas, on April 26-29, 2009. Quick-Med’s
scientists will present four abstracts at the prestigious meeting. |
| Read More... |
| 03/24/2009 - Quick-Med and Foster Enter Into
Joint Development Agreement |
| 03/03/2009 - Quick-Med Granted Additional NIMBUS® Patent |
| 26/02/2009 - FDA Clears First Quick-Med Product |
| 11/18/2008 - New Study Reaffirms Quick-Med’s NIMBUS®
Technology Poses No Threat of Bacterial Resistance |
| 06/11/2008 - Quick-Med Technologies, Inc. Signs Manufacturing and Distribution Agreement with BASF Beauty Care Solutions |
| 05/21/2008 - NIMBUS®, NimbuDerm™ and MultiStat™ Technologies Selected for Presentation at Prestigious 3rd Congress of the World Union of Wound Healing Societies in Toronto |
| 05/15/2008 - Quick-Med’s Novel Wound Dressing Receives Recognition from the Wound Healing Society |
05/14/2008 - NimbuDerm™ Receives Wound Healing Society’s Blue Ribbon Award
|
| 04/10/2008 - Quick-Med Technologies, Inc. Signs Joint Development
Agrement with a Leading Provider of
Health Care Products |
| 04/08/2008 - Quick-Med Technologies Presenting at Prestigious SAWC/WHS Conference |
| 03/11/2008 - Quick-Med Technologies is Developing a
Next Generation Skin Sanitizer Technology to Provide
Long-Lasting Protection from MRSA |
| 02/12/2008 - Quick-Med Technologies’ Research & Development Center Moves to New Location |
| 02/01/2008 - Dr. Olderman Highlights the Value of a Bonded Antimicrobial at Textiles Conference |
| 08/09/2007 - Quick-Med Technologies Announces CEO Appointment |
| 08/02/2007 - Mexico grants Quick-Med Technologies, Inc. Notice of Allowance for its NIMBUS® Technology |
| 06/19/2007 - Quick-Med Technologies, Inc. and the University of Michigan Sign Patent Licensing Agreement |
| 04/24/2007 - Quick-Med Technologies, Inc. Awarded $1 Million Congressional Appropriation |
04/02/2007 - Quick-Med Technologies, Inc. Licenses NIMBUS Anti microbial
Technology To Derma Sciences, Inc. For Use In Wound Care Products
|
| 03/26/2007 - Quick-Med Technologies' Lead Molecule Ilomastat Selected for
Evaluation in Sulfur Mustard Gas Grant from NIH |
| 07/10/2006 - Quick-Med Technologies, Inc. Resolves Dispute With Cosmetics Distribution Partner |
| 07/26/2006 - Quick-Med Technologies, Inc. Competitively Selected By U.S. Army For a $770,000 Phase II SBIR Grant |
| 06/01/2006 - Quick-Med Technologies, Inc. to Address
Congressional 21st Century Health Care Caucus on Hospital Infection Prevention |
| 05/31/2006 - Quick-Med Technologies, Inc. Receives Wound Healing Society's Prestigious Blue Ribbon Award |
03/16/2006 - Quick-Med Technologies, Inc. Senior Scientist
Gregory S. Schultz Profiled in TIME Magazine
01/09/2006 - Cheryl L. Turnbull Elected to Board of Directors of Quick-Med Technologies, Inc.
12/08/2005 - Quick-Med Technologies, Inc. Receives Key Patent On Its NIMBUS™ Technology
U.S. Patent Allowance Significantly Strengthens Overall Patent Portfolio
11/15/2005 - Quick-Med Technologies, Inc. Awarded U.S. Army SBIR Phase I Contract
09/13/2005 - Quick-Med Technologies, Inc. and The University of Florida Collaborate to Develop The Next Generation of NIMBUS™ Anti microbial Technology
01/13/2005 - Quick-Med Technologies, Inc. Retains Elman Technology Law, P.C. |
| News Archive... |
 |
| |
|
 Time Magazine - Index: March 20, 2006 Vol. 167 No. 12
Sunday, Mar. 12, 2006
What's Next? The Next Big Thing Is Us....
Innovators / Epidemiology: Forging the Future
Microbe-Busting Bandages
By SIOBHAN MORRISSEY/MIAMI
What do jock itch, poison gas and flesh-eating bacteria have in common? Gregory Schultz, 56, thinks he has the answer. The cancer researcher turned inventor has patented a technique for chemically bonding bacteria-fighting polymers to such fabrics as gauze bandages, cotton T shirts and men's underpants. It's a technology with an unusually wide variety of uses, from underwear that doesn't stink to hospital dressings that thwart infections.
To read full article click here... |
| |
|
|
|
|
|
